These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 32519936

  • 1. Occurrence of ESBL-Producing Escherichia coli ST131, Including the H30-Rx and C1-M27 Subclones, Among Urban Seagulls from the United Kingdom.
    Zendri F, Maciuca IE, Moon S, Jones PH, Wattret A, Jenkins R, Baxter A, Timofte D.
    Microb Drug Resist; 2020 Jun; 26(6):697-708. PubMed ID: 32519936
    [Abstract] [Full Text] [Related]

  • 2. Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom.
    Timofte D, Maciuca IE, Williams NJ, Wattret A, Schmidt V.
    Microb Drug Resist; 2016 Oct; 22(7):609-615. PubMed ID: 27314838
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C, Xu X, Pu S, Huang S, Sun J, Yang S, Zhang L.
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rapid Identification of Different Escherichia coli Sequence Type 131 Clades.
    Matsumura Y, Pitout JDD, Peirano G, DeVinney R, Noguchi T, Yamamoto M, Gomi R, Matsuda T, Nakano S, Nagao M, Tanaka M, Ichiyama S.
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584160
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe.
    Merino I, Hernández-García M, Turrientes MC, Pérez-Viso B, López-Fresneña N, Diaz-Agero C, Maechler F, Fankhauser-Rodriguez C, Kola A, Schrenzel J, Harbarth S, Bonten M, Gastmeier P, Canton R, Ruiz-Garbajosa P, R-GNOSIS Study Group.
    J Antimicrob Chemother; 2018 Nov 01; 73(11):2973-2980. PubMed ID: 30124851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
    Maciuca IE, Williams NJ, Tuchilus C, Dorneanu O, Guguianu E, Carp-Carare C, Rimbu C, Timofte D.
    Microb Drug Resist; 2015 Dec 01; 21(6):651-62. PubMed ID: 25734920
    [Abstract] [Full Text] [Related]

  • 13. Wild Birds, Frequent Carriers of Extended-Spectrum β-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types.
    Alcalá L, Alonso CA, Simón C, González-Esteban C, Orós J, Rezusta A, Ortega C, Torres C.
    Microb Ecol; 2016 Nov 01; 72(4):861-869. PubMed ID: 26687342
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs.
    Aslantaş Ö, Yilmaz EŞ.
    J Vet Med Sci; 2017 Jun 16; 79(6):1024-1030. PubMed ID: 28450661
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of CTX-M-Type Extended-Spectrum β-Lactamase-Producing Escherichia coli B2-O25-ST131 H30R Among Residents in Nonacute Care Facilities in Japan.
    Kawamura K, Hayashi K, Matsuo N, Kitaoka K, Kimura K, Wachino JI, Kondo T, Iinuma Y, Murakami N, Fujimoto S, Arakawa Y.
    Microb Drug Resist; 2018 Dec 16; 24(10):1513-1520. PubMed ID: 29791251
    [Abstract] [Full Text] [Related]

  • 17. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from the rivers and lakes in Northwest China.
    Liu H, Zhou H, Li Q, Peng Q, Zhao Q, Wang J, Liu X.
    BMC Microbiol; 2018 Oct 04; 18(1):125. PubMed ID: 30286725
    [Abstract] [Full Text] [Related]

  • 18. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR, Johnston B, Kuskowski MA, Sokurenko EV, Tchesnokova V.
    Antimicrob Agents Chemother; 2015 Aug 04; 59(8):4471-80. PubMed ID: 25987621
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD, Thuras PD, Johnson JR.
    Diagn Microbiol Infect Dis; 2020 Jul 04; 97(3):115034. PubMed ID: 32331800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.